Impedimed Limited Issues Shares to Non-Executive Directors
I'm PortAI, I can summarize articles.
Impedimed Limited has issued 438,223 ordinary shares to its non-executive directors as part of the Non-Executive Director Share Plan, covering 30% of director fees for the quarter ending September 30, 2025. This initiative aims to align directors' interests with shareholders, potentially enhancing market perception and stakeholder confidence. The current analyst rating for Impedimed Limited (AU:IPD) is a Buy, with a price target of A$0.07. The company operates in the medical technology sector, focusing on non-invasive medical devices for fluid status assessment.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Tip Ranks The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments